Judge Buries Barr's Plan For Generic Argatroban
A federal judge has handed a victory to GlaxoSmithKline PLC, Mitsubishi Chemical Corp. and Encysive Pharmaceuticals Inc. in their patent infringement battle with Barr Laboratories over the anti-blood-clotting drug Argatroban, forbidding...To view the full article, register now.
Already a subscriber? Click here to view full article